Results 201 to 210 of about 146,560 (338)
Genetically Validated Immune Susceptibility Markers for Crohn's Disease: A Multi-Omics Mendelian Randomization Analysis. [PDF]
Li Z.
europepmc +1 more source
Treatment of pyoderma gangrenosum (PG) complicating Crohn's disease (CD) with infliximab
John J. Hong +2 more
openalex +1 more source
CLINICOPATHOLOGIC PECULIARITIES OF NONSPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE
S. D. Strelkova +5 more
openalex +1 more source
Abstract Objective Multidisciplinary care is recommended for pediatric inflammatory bowel disease (IBD). This study aims to describe provider attitudes, barriers, and facilitators regarding multidisciplinary care in pediatric IBD, and explore associations between multidisciplinary care access and center‐level factors.
Nicole Davidson +6 more
wiley +1 more source
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling +2 more
wiley +1 more source
Cutaneous and Genitalia Inflammation Treated With Guselkumab and Antimicrobial Therapy in a Patient with a History of Crohn's Disease. [PDF]
Nikzad N +6 more
europepmc +1 more source
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
Mariam Aguas
openalex +2 more sources
Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy [PDF]
James Turvill
openalex +1 more source
Gastrointestinal strictures in a pediatric patient with Satoyoshi syndrome
Abstract We present a novel case of gastrointestinal strictures in a young girl with Satoyoshi syndrome (SS), highlighting multi‐system features of alopecia universalis, painful muscle cramps with dystonia, aberrant growth velocity, and skeletal abnormalities.
Katherine (Tusia) Pohoreski +5 more
wiley +1 more source

